Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Predictors for Successful Neurofeedback Training (Predictors)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03297437
Recruitment Status : Recruiting
First Posted : September 29, 2017
Last Update Posted : October 2, 2017
Sponsor:
Information provided by (Responsible Party):
Frank Scharnowski, Psychiatric University Hospital, Zurich

Brief Summary:
The primary objective of this study is to identify predictors of neurofeedback training success.

Condition or disease Intervention/treatment Phase
Healthy Other: Neurofeedback training Not Applicable

Detailed Description:
In the last decades, neurofeedback has been established as a promising scientific tool. Learning voluntary control over their own brain activity allows for establishing causal links between brain activity and mental functions. However, patients participants differ in their ability to learn control over their own brain activity with neurofeedback. It is thus crucial to understand why some participants are more successful in regulating their own brain activity than others. The objective of the present study is thus to identify predictors for successful learning self-regulation with real-time fMRI neurofeedback. To achieve this goal, we will evaluate the introspection ability of healthy participants using standardized psychological questionnaires and tasks. These scores will then be correlated with how well they learned self-regulation skills using established real-time fMRI neurofeedback protocols.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 192 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose: Basic Science
Official Title: Predictors for Successful Neurofeedback Training
Estimated Study Start Date : October 1, 2017
Estimated Primary Completion Date : September 30, 2021
Estimated Study Completion Date : September 30, 2021

Intervention Details:
  • Other: Neurofeedback training
    In a neurofeedback setting, brain activity is measured non-invasively, the brain imaging data is analyzed in real-time, and then feedback regarding the current level of brain activity is provided to the subject.


Primary Outcome Measures :
  1. correlation between introspection scores and learning success [ Time Frame: 48 months ]
    The primary outcome measure is a correlation between introspection scores and neurofeedback learning success across all subjects.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 65 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

Age 18 - 65 years. Magnetic resonance imaging compatibility.

Exclusion Criteria:

Physical or psychiatric disorders (DSM-V diagnosis). Current substance abuse. Exclusion criteria applicable to MRI (metallic implants, claustrophobia, epilepsy).


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03297437


Contacts
Layout table for location contacts
Contact: Frank Scharnowski, Prof. Dr. +41443842953 Frank.Scharnowski@uzh.ch

Locations
Layout table for location information
Switzerland
Hospital of Psychiatry, University of Zurich Recruiting
Zürich, Zürich-, Switzerland, 8032
Contact: Frank Scharnowski, Prof. Dr.    +41443842953    Frank.Scharnowski@uzh.ch   
Contact: Ronald Sladky, PD Dr.    +41443842667    ronald.sladky@uzh.ch   
Sponsors and Collaborators
Frank Scharnowski

Layout table for additonal information
Responsible Party: Frank Scharnowski, Prof. Dr., Psychiatric University Hospital, Zurich
ClinicalTrials.gov Identifier: NCT03297437     History of Changes
Other Study ID Numbers: PsychiatricUHZPUK
First Posted: September 29, 2017    Key Record Dates
Last Update Posted: October 2, 2017
Last Verified: September 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No